Adamis Pharmaceuticals Corp expected to post a loss of 6 cents a share - Earnings Preview

DMK Pharmaceuticals

13/11/2021 01:22

* Adamis Pharmaceuticals Corp  ADMP.OQ   ADMP.O  is expected
to show a fall in quarterly revenue when it reports  results on
November 15 (estimated). 
* The San Diego, California-based company is expected to report 
a 25.7% decrease in revenue to $3.466 million from $4.66 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Adamis Pharmaceuticals
Corp is for a loss of 6 cents per share. For the same quarter
last year, the company reported a loss of 15 cents per share.
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
This summary was machine generated November 13 at 01:22 GMT. 
All figures in US dollars  unless otherwise stated